Baltic Countries

Genome Project Ends the Pilot Phase and Starts the Main Project


Tartu - After having achieved the principal goals of the pilot project, the Estonian Genome Project Foundation (EGPF) declared the pilot project in three counties completed and started the main project, covering nearly the whole of Estonia.
“The principal goal of the pilot project has been achieved - technical and organizational readiness for carrying out the main project over all Estonia has been obtained and the investments to begin expanding the project have been incorporated”, said Krista Kruuv, Chairman of the Management Board of EGPF.
Data collection will continue in the counties of the pilot project - namely Tartu, West Viru and Saare. The other regions of Estonia will be included step by step. At the first stage of the expansion of the Genome Project, Jogeva, Viljandi and Parnu counties will be included, the data collection has been started in April. In summer, Voru, Polva and Valga counties will join the project. The next joining counties are Laane, Rapla and Jarva counties, where the data collection will start in autumn. Part of the Harju county will also be included this year. Tallinn - the capital of Estonia - and East Viru county will join the project in the first half of the year 2004.
During the main project genotype data will be added in addition to phenotype data in the Estonian Gene Bank. “We envisage that genotyping could start within two or three years,” said Kruuv.
The objective of the Estonian Genome Project is to establish a database of health and genetic data of the people of Estonia that enables more exact and efficient diagnoses of illnesses, improvement of treatment and determination of risks of the development of an illness in the future. The data collection in the counties of the pilot project began in October 2002 (see EuroBiotechNews 1/02). The number of gene donors was nearly a thousand in the end of the pilot project. There were more than 50 data collectors involved.

Baltic Countries


Under the motto “10 Years ScanBalt Bioregion – Towards a Balanced Regional Development and Smart Specialisation in the Baltic Sea Region”, the ScanBalt Bio­Region is holding the 10th ScanBalt Forum from September 21st-23rd....

Baltic Countries


Kaunas – US-based Valeant Pharmaceuticals International Inc. said in mid-May that it is purchasing an 87.2% share in Lithuanian generic drug maker Sanitas AB for EUR314m in cash, and will make a mandatory tender offer to acquire...

Baltic Countries


Kaunas – US company Valeant Pharmaceuticals International, Inc. wants to purchase Lithuanian generic drug maker Sanitas AB for EUR314 million in cash. Shareholders of Sanitas have already agreed to sell Valeant 87.2% of Sanitas’...

Baltic Countries


Bucharest – Plans by Romanian Environment Minister Lazlo Borbely to implement a five-year ban on GMO acreage beginning next spring have been fiercely attacked by the country’s Agriculture Minister Valeriu Tabara. Borbely has...

Baltic Countries


Kopavogur – Iceland’s ORF Genetics Ltd. and the Indian company DM Corp. Pvt. Ltd. are planning to collaborate on the development, production and marketing of protein drugs. The two CEOs Björn Örvar (ORF) and Dilip Mohite (DM...

Baltic Countries


Vilnius/Waltham – Lab giant Thermo Fisher Scientific has completed its EUR212m cash takeover of Lithuania‘s largest lab tools provider Fermentas Inter­na­tional. Integration of the firm into Thermo Fisher’s Analytical...

Baltic Countries


Riga – According to an announcement following a meeting of senior staff in mid-August, JCS Grindeks will collaborate in product development with the Latvian Institute of Organic Synthesis (IOS). The collaboration will involve the...

Baltic Countries


Riga – Latvian pharma manufacturing firm Grindeks has announced it will significantly increase revenues to EUR13.5m this year. Issued in mid-June, the prognosis was based on good sales in eastern European markets in the first...

Baltic Countries


Vilnius/Waltham – The life sciences tools market is slowly being whittled down to a few major players. At the end of May, Lithuania’s largest lab supplier was the most recent target of an acquisition, when US lab giant Thermo...

Displaying results 1 to 10 out of 58

1-10 Next >

© 2007-2016 BIOCOM


Current issue

All issues

Product of the week


Stock list

All quotes


  • MOLMED (I)0.42 EUR7.69%


  • PHOTOCURE (N)46.40 NOK-8.12%
  • VERNALIS (UK)43.00 GBP-4.44%
  • E-THERAPEUTICS (UK)11.75 GBP-4.08%


  • DIAMYD MEDICAL -B- (S)7.05 SEK67.9%
  • KARO BIO (S)38.30 SEK33.4%
  • NEWRON (CH)20.65 CHF24.8%


  • BIONOR PHARMA (N)0.47 NOK-23.0%
  • NOVOZYMES (DK)284.10 DKK-14.4%
  • WILEX (D)1.53 EUR-12.6%


  • KARO BIO (S)38.30 SEK2453.3%
  • NICOX (F)10.33 EUR470.7%
  • SAREUM HOLDINGS (UK)0.74 GBP252.4%


  • BB BIOTECH (D)46.45 EUR-80.4%
  • EVOCUTIS (UK)0.04 GBP-78.9%
  • NOVACYT (F)1.30 EUR-70.4%

No liability assumed, Date: 23.08.2016


All Events